Table 1.
Clinical characteristic of the study subjects n (%)
| Variable | Value |
| Hepatocellular carcinoma | n = 52 |
| Age (mean ± SD) | 50.2 ± 17.5 |
| Sex | |
| Male | 46 (88.5) |
| Female | 6 (11.5) |
| AFP | |
| ≥ 200 μg/L | 32 (61.5) |
| < 200 μg/L | 20 (38.5) |
| HbsAg | |
| Positive | 52 (100) |
| Negative | 0 (0) |
| Child-Pugh classification | |
| A | 35 (67.3) |
| B | 17 (32.7) |
| Tumor size cm (mean ± SD) | 2.0 ± 1.0 (1.0-3.1) |
| Multiple tumors | |
| Yes | 10 (19.2) |
| No | 42 (80.8) |
| Tumor location | |
| Liver segment I | 0 (0) |
| Liver segment II | 3 (4.8) |
| Liver segment III | 7 (11.3) |
| Liver segment IV | 7 (11.3) |
| Liver segment V | 9 (14.5) |
| Liver segment VI | 11 (17.7) |
| Liver segment VII | 12 (19.4) |
| Liver segment VIII | 13 (21.0) |
| Background liver cirrhosis | |
| Present | 46 (88.5) |
| Absent | 6 (11.5) |